What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020)
Objective To examine factors associated with accrual rate in industry sponsored clinical trials supporting US Food and Drug Administration (FDA) cancer drug approvals from 2015 to 2020.Design, setting and participants Retrospective cross-sectional study included 194 pivotal trials supporting cancer...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/10/e064458.full |